Omnibus Cosmetic Regulation

Omnibus Regulation VII

The European Commission notified to the World Trade Organization (WTO) the “Omnibus VII” regulation on the 24th of June. The adoption is expected to take place during the 3rd quarter of 2025.

This regulation incorporates substances classified CMR by the regulation EC 2024/197, a.k.a. ATP 21 of the CLP Regulation (see IL-125 for more details) into the European Cosmetic Regulation 1223/2009. None of these substances have been defended by the industry. They will therefore be included in Annex II (prohibited substances) of the Cosmetics Regulation.

Among these newly CMR classified substances, two ingredients are used in cosmetic products:

  • DIMETHYLTOLYLAMINE (CAS 99-97-8)
  • TPO (TRIMETHYLBENZOYL DIPHENYLPHOSPHINE OXIDE CAS 75980-60- 8).

Products containing any of these two ingredients will be forbidden on September 1st, 2025. This means that no product unit containing them can be available on the EU market after that date.

We hope that this letter will be of help and stay at your disposal for any questions related to this topic. Should you have any question, please, feel free to contact your dedicated Customer Relationship Manager.

Author

  • Stéphanie Annet

    Stéphanie is Biorius's Cosmetic Regulatory Affairs Lead & Customer Data Manager and works in the cosmetic industry for almost 10 years.



    View all posts


    Cosmetic Regulatory Affairs Lead & Customer Data Manager